https://www.selleckchem.com/products/azd9291.html
Based on the broad-spectrum analysis and interactome analysis, we identified NAD(P)Hquinone oxidoreductase, dCTP deaminase, Phosphotransferase, and ATP-dependent Clp protease adapter (ClpS) as the most potential therapeutic targets. Notably, phosphotransferase and ClpS are new targets, i.e., they do not interact with any experimental or approved drugs. Overall, our study will guide the development of new and effective drugs for the treatment of Stenotrophomonas maltophilia infection.Since its first identification in 2016, porcine circov